m (Text replacement - "[ \s]User:Curator 83" to " Ch") |
(mobo import Concept___Events_With_Academic_Fields-migrated) |
||
| Line 3: | Line 3: | ||
|Title=ICPSB 2018 : 2018 2nd International Conference on Pharma Sciences and Biotechnology (ICPSB 2018) | |Title=ICPSB 2018 : 2018 2nd International Conference on Pharma Sciences and Biotechnology (ICPSB 2018) | ||
|Type=Conference | |Type=Conference | ||
| − | |||
|City=Jeju | |City=Jeju | ||
|Country=South Korea | |Country=South Korea | ||
| Line 14: | Line 13: | ||
|Start Date=2018/01/18T12:00:00 | |Start Date=2018/01/18T12:00:00 | ||
|End Date=2018/01/20T12:00:00 | |End Date=2018/01/20T12:00:00 | ||
| + | |Academic Field=Biomedical Engineering | ||
}} | }} | ||
Welcome to join in the 2018 2nd International Conference on Pharma Sciences and | Welcome to join in the 2018 2nd International Conference on Pharma Sciences and | ||
Revision as of 13:24, 24 August 2022
Welcome to join in the 2018 2nd International Conference on Pharma Sciences and Biotechnology (ICPSB 2018), which will be held in Jeju, South Korea during January 18-20, 2018.
For papers submitted to ICPSB 2018, we offer the publications as following:
1. Publication in Journal. Submissions will be reviewed by the conference committees and journal editorial board, and accepted papers will be published in the International Journal of Pharma Medicine and Biological Sciences, which will be indexed by Embase; ProQuest; International Committee of Medical Journal Editors (ICMJE); Health sciences library (NYU); HINARI Access to Research in Health Programme; etc.
There are two methods for submitting your paper:
1. By our electric system: http://www.easychair.org/conferences/?conf=icpsb2018
2. By our contact email box: icpsb@etpub.com
Please feel free contact with us: Scene Chiang (Conference Secretary) E-mail: icpsb@etpub.com Tel: +1-858-866-9105 (USA) +86-28-86512185 (China)
For more information about international conferences, please visit our conference website: ICPSB 2018 website: http://www.icpsb.org/index.html
